| Literature DB >> 31967332 |
Xueming Cao1, Na Zhu2, Yuwei Zhang3, Yan Chen1, Jing Zhang1, Jiang Li4, Peiyuan Hao1, Chuanyu Gao1, Li Li5.
Abstract
Cardiomyocyte apoptosis induced by hypoxia and ischemia plays important roles in heart dysfunction after acute myocardial infarction (AMI). However, the mechanism of apoptosis induction remains unclear. A previous study reported that Y-box protein 1 (YB1) is upregulated after myocardial hypoxia/reoxygenation or ischemia/reperfusion (H/R or I/R, respectively) injury; however, whether YB1 is associated with H/R-induced cardiomyocyte apoptosis is completely unknown. In the present study, we investigated the roles of YB1 in H/R-induced cardiomyocyte apoptosis and the possible underlying molecular mechanisms. In vitro, H/R treatment upregulated the YB1 expression in H9C2 cells, whereas YB1 knockdown inhibited H/R-induced cardiomyocyte apoptosis and induced H9C2 cell proliferation via Src homology region 2 domain-containing phosphatase 1 (SHP-1)-mediated activation of signal transducer and activator of transcription 3 (STAT3). In vivo, YB1 knockdown ameliorated AMI, reducing infarct size, cardiomyocyte apoptosis, and oxidative stress, via SHP-1-mediated inactivation of STAT3. Additionally, YB1 knockdown inhibited H/R- or I/R-induced oxidative stress in vitro and in vivo. H/R and I/R increase YB1 expression, and YB1 knockdown ameliorates AMI injury via SHP-1-dependent STAT3 inactivation.Entities:
Keywords: SHP-1; STAT3; Y-box protein 1; acute myocardial infarction; cardiomyocyte apoptosis; hypoxia/reoxygenation; ischemia/reperfusion
Mesh:
Substances:
Year: 2020 PMID: 31967332 DOI: 10.1002/jcp.29474
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384